NAT10 expression is notably higher in cancer tissues than in normal tissues, with elevated levels linked to poor prognostic outcomes in head and neck squamous cell carcinoma, hepatocellular carcinoma, and pancreatic cancer [43, 50]. This evidence concerns the gene NAT10 and pancreatic neoplasm.